Personal information

No personal information available

Activities

Works (5)

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.

Nature communications
2021-04-22 | Journal article
Source: Self-asserted source
Michael Allevato

HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.

Oncogene
2020-08-26 | Journal article
Source: Self-asserted source
Michael Allevato

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.

Nature communications
2019-12-05 | Journal article
Source: Self-asserted source
Michael Allevato

4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.

Cancer research
2019-03-20 | Journal article
Source: Self-asserted source
Michael Allevato

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs.

PloS one
2017-07-18 | Journal article
Source: Self-asserted source
Michael Allevato